Asset
BOTULINUM TOXIN
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02334436 | phase3 | completed | 2015-01-01 | 2015-09-01 | Evolus, Inc. | A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 |
| NCT02334423 | phase3 | completed | 2015-01-01 | 2015-12-01 | Evolus, Inc. | A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001 |
FDA applications (0)
This company has no applications containing this asset.